Login / Signup

Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults.

Devyani JoshiLindsay E NyhoffVeronika I ZarnitsynaAlberto MorenoKelly ManningSusanne LindermanAllison R BurrellKathy StephensCarson NorwoodGrace MantusRafi AhmedEvan J AndersonMary A StaatMehul S SutharJens Wrammert
Published in: medRxiv : the preprint server for health sciences (2023)
Since the emergence of SARS-CoV-2, research has shown that adult patients mount broad and durable immune responses to infection. However, response to infection remains poorly studied in infants/young children. In this study, we evaluated humoral responses to SARS-CoV-2 in 23 infants/young children before and after infection. We found that antibody responses to SARS-CoV-2 spike antigens peaked approximately 30 days after infection and were maintained up to 500 days with little apparent decay. While the magnitude of humoral responses was similar to an adult cohort recovered from mild/moderate COVID-19, both binding and neutralization titers to WT SARS-CoV-2 were more durable in infants/young children, with Spike and RBD IgG antibody half-life nearly 4X as long as in adults. The functional breadth of adult and infant/young children SARS-CoV-2 responses were comparable, with similar reactivity against panel of recent and previously circulating viral variants. Notably, IgG subtype analysis revealed that while IgG1 formed the majority of both adults' and infants/young children's response, IgG3 was more common in adults and IgG2 in infants/young children. These findings raise important questions regarding differential regulation of humoral immunity in infants/young children and adults and could have broad implications for the timing of vaccination and booster strategies in this age group.
Keyphrases
  • sars cov
  • immune response
  • respiratory syndrome coronavirus
  • dendritic cells
  • magnetic resonance imaging
  • high intensity
  • coronavirus disease
  • magnetic resonance
  • single cell
  • binding protein
  • genome wide